Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model

Blood

Volumn 94, Issue 11, 1999, Pages 3722-3729

  Cashman, J D ^b   Clark Lewis, I ^b   Eaves, A C ^a,b   Eaves, C J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; DOWN REGULATION; GRANULOPOIESIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033485307     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3722.423k20_3722_3729     Document Type: Article

References (60)

1. Migliaccio G, Migliaccio AR, Adamson JW: In vitro differentiation of human granulocyte/macrophage and erythroid progenitors: Comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum-deprived cultures. Blood 72:248, 1988
2. Keller JR, Jacobsen SEW, Dubois CM, Hestdal K, Ruscetti FW: Transforming growth factor-β : A bidirectional regulator of hematopoietic cell growth. Int J Cell Cloning 10:2, 1992
3. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
4. McArthur GA, Rohrschneider LR, Johnson GR: Induced expression of c-fins in normal hematopoietic cells shows evidence for both conservation and lineage restriction of signal transduction in response to macrophage colony-stimulating factor. Blood 83:972, 1994
5. McArthur GA, Longmore GD, Klingler K, Johnson GR: Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR. Exp Hematol 23:645, 1995
6. van de Ven C, Ishizawa L, Law P, Cairo MS: IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expanison of isolated CD34+ cell population from cord blood vs. adult bone marrow. Exp Hematol 23:1289, 1995
7. -) human hematopoietic cells: Novel responses to flt3-ligand and thrombopoietin. J Exp Med 183:2551, 1996
8. Krystal G, Lam V, Dragowska W, Takahashi C, Appel J, Gontier A, Jenkins A, Lam H, Quon L, Lansdorp P: Transforming growth factor β1 is an inducer of erythroid differentiation. J Exp Med 180:851, 1994
9. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ: Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 94:4698, 1997
10. Zandstra PW, Conneally E, Piret JM, Eaves CJ: Ontogeny-associated changes in the cytokine responses of primitive human haematopoietic cells. Br J Haematol 101:770, 1998
11. +++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp Hematol 21:1442, 1993
12. + cells purified from cord blood and fetal liver. Exp Hematol 23:422, 1995
13. Brady G, Billia F, Knox J, Hoang T, Kirsch IR, Voura EB, Hawley RG, Cumming R, Buchwald M, Siminovitch K, Miyamoto N, Boehmelt G, Iscove NN: Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr Biol 5:909, 1995
14. Wagner JE, Collins D, Fuller S, Schain LR, Berson AE, Almici C, Hall MA, Chen KE, Okarma TB, Lebkowski JS: Isolation of small, primitive human hematopoietic stem cells: Distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 86:512, 1995
15. Cheng T, Shen H, Giokas D, Gere J, Tenen DG, Scadden DT: Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc Natl Acad Sci USA 93:13158, 1996
16. McKinstry WJ, Li CL, Rasko JEJ, Nicola NA, Johnson GR, Metcalf D: Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89:65, 1997
17. Roberts AW, Zaiss M, Boyd AW, Nicola NA: G-CSF-mobilized peripheral blood progenitor cells: In vitro growth pattern and hematopoietic growth factor receptor profile. Exp Hematol 25:298, 1997
18. Bello-Fernandez C, Matyash M, Strobl H, Scheinecker C, Knapp W: Analysis of myeloid-associated genes in human hematopoietic progenitor cells. Exp Hematol 25:1158, 1997
19. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C, Enver T: Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev 11:774, 1997
20. Cashman J, Eaves AC, Eaves CJ: Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood 66:1002, 1985
21. Eaves C, Eaves A: Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro. Blood Cells 20:83, 1994
22. Cashman JD, Eaves CJ, Sarris AH, Eaves AC: MCP-1, not MIP-1α is the endogenous chemokine that cooperates with TGF-β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures. Blood 92:2338, 1998
23. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
24. Eaves CJ, Cashman JD, Wolpe SD, Eaves AC: Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1α, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci USA 90:12015, 1993
25. Cashman JD, Eaves AC, Eaves CJ: Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-β on normal and leukemic human hematopoietic progenitor cells. Leukemia 6:886, 1992
26. Cashman JD, Lapidot T, Wang JCY, Doedens M, Shultz LD, Lansdorp P, Dick JE, Eaves CJ: Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89:4307, 1997
27. Cashman J, Bockhold K, Hogge DE, Eaves AC, Eaves CJ: Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haematopoietic cells in NOD/SCID mice transplanted with human cord blood. Br J Haematol 98:1026, 1997
28. Sutherland HJ, Eaves CJ: Long-term culture of human myeloid cells, in Freshney RI, Pragnell IB, Freshney MG, (eds): Culture of Hematopoietic Cells, New York, NY, Wiley, 1994, p 139
29. Hunter MG, Bawden L, Brotherton D, Craig S, Cribbes S, Czaplewski LG, Dexter TM, Drummond AH, Gearing AH, Heyworth CM, Lord BI, McCourt M, Varley PG, Wood LM, Edwards RM, Lewis PJ: BB-10010: An active variant of human macrophage inflammatory protein-1α with improved pharmaceutical properties, Blood 86:4400, 1995
30. Gong J-H, Ratkay LG, Waterfield JD, Clark-Lewis I: An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 186:131, 1997
31. 2-terminal residues. J Exp Med 181:631, 1995
32. Gong J-H, Uguccioni M, Dewald B, Baggiolini M, Clark-Lewis I: RANTES and MCP-3 antagonists bind multiple chemokine receptors. Cytokine 271:10521, 1996
33. Ishibashi T, Miller SL, Burstein SA: Type β transforming growth factor is a potent inhibitor of murine megakaryocytopoiesis in vitro. Blood 69:1737, 1987
34. Unkeless JC: Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580, 1979
35. Schmitt C, Eaves CJ, Lansdorp PM: Expression of CD34 on human B cell precursors. Clin Exp Immunol 85:168, 1991
36. Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ: Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor. Blood 88:3765, 1996
37. Ponchio L, Conneally E, Eaves C: Quantitation of the quiescent fraction of long-term culture-initiating cells (LTC-IC) in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. Blood 86:3314, 1995
38. Migdalska A, Molineux G, Demuynck H, Evans GS, Ruscetti F, Dexter TM: Growth inhibitory effects of transforming growth factor-β1 in vivo. Growth Factors 4:239, 1991
39. 1 on hematologic recovery after treatment of mice with 5-fluorouracil. J Immunol 147:3342, 1991
40. Dunlop DJ, Wright EG, Lorimore S, Graham GJ, Holyoake T, Kerr DJ, Wolpe SD, Pragnell IB: Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1α in vivo. Blood 79:2221, 1992
41. Lord BI, Dexter TM, Clements JM, Hunter MA, Gearing AJH: Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 79:2605, 1992
42. Broxmeyer HD, Cooper S, Hague N, Benninger L, Sarris A, Cornetta K, Vadhan-Raj S, Hendrie P, Mantel C: Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann Hematol 71:235, 1995
43. Gao J-L, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J. Murphy PM: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185:1959, 1997
44. Reid S, Ritchie A, Boring L, Gosling J, Cooper S, Hangoc G, Charo IF, Broxmeyer HE: Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2. Blood 93:1524, 1999
45. Quesniaux VFJ, Graham GJ, Pragnell I, Donaldson D, Wolpe SD, Iscove NN, Fagg B: Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1α on long-term reconstituting stem cells in vivo. Blood 81:1497, 1993
46. Eaves AC, Barnett MJ, Ponchio L, Cashman JD, Petzer A, Eaves CJ: Differences between normal and CML stem cells: Potential targets for clinical exploitation. Stem Cells 16:77, 1998
47. Eaves C, Cashman J, Eaves A: Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia. Leuk Res 22:1085, 1998
48. Bernstein SH, Eaves CJ, Herzig R, Fay J, Lynch J, Phillips GL, Christiansen N. Reese D, Ericson S, Stephan M, Kovalsky M, Hawkins K, Rasmussen H, de Vos A, Herzig GP: A randomized phase II study of BB-10010: A variant of human macrophage inflammatory protein-1α for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer. Br J Haematol 99:888, 1997
49. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Péault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804, 1992
50. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE: Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78:666, 1991
51. Zanjani ED, Pallavicini MG, Ascensao JL, Flake AW, Langlois RG, Reitsma M, MacKintosh FR, Stutes D, Harrison MR, Tavassoli M: Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 89:1178, 1992
52. Kamel-Reid S, Dick JE: Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706, 1988
53. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992
54. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
55. Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A: Macrophage inflammatory protein (MIP)-1β abrogates the capacity of MIP-1α to suppress myeloid progenitor cell growth. J Immunol 147:2586, 1991
56. Pereira RF, Halford KW. O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop DJ: Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92:4857, 1995
57. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP: Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584, 1997
58. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964, 1997
59. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528, 1998
60. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MAS, Storb RF, Hammond WP: Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362, 1998